The spectrum of polycystic kidney disease in children.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 3168776)

Published in Adv Chronic Kidney Dis on September 01, 2011

Authors

Katherine MacRae Dell1

Author Affiliations

1: Division of Pediatric Nephrology, Department of Pediatrics, Rainbow Babies and Children's Hospital and Case Western Reserve University, Cleveland, OH 44106, USA. Katherine.Dell@case.edu

Articles cited by this

Autosomal dominant polycystic kidney disease. Lancet (2007) 8.55

Autosomal dominant polycystic kidney disease. N Engl J Med (1993) 5.64

Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med (2010) 5.50

The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A (2006) 4.56

The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet (2002) 4.54

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med (2010) 4.36

Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol (2008) 4.07

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med (2003) 3.78

Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet (1994) 3.73

Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation (2008) 3.33

PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet (2002) 3.21

Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases. Nat Clin Pract Nephrol (2006) 2.95

Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics (2003) 2.89

Role of primary cilia in the pathogenesis of polycystic kidney disease. J Am Soc Nephrol (2007) 2.44

Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2009) 2.42

Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) (2006) 2.34

EGF-related growth factors in the pathogenesis of murine ARPKD. Kidney Int (2004) 1.81

Caroli's disease and outcomes after liver transplantation. Liver Transpl (2008) 1.78

Heightened epithelial Na+ channel-mediated Na+ absorption in a murine polycystic kidney disease model epithelium lacking apical monocilia. Am J Physiol Cell Physiol (2005) 1.74

Autosomal-dominant polycystic kidney disease in infancy and childhood: progression and outcome. Kidney Int (2005) 1.72

Mechanoregulation of intracellular Ca2+ concentration is attenuated in collecting duct of monocilium-impaired orpk mice. Am J Physiol Renal Physiol (2005) 1.66

Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int (2005) 1.55

Liver and kidney disease in ciliopathies. Am J Med Genet C Semin Med Genet (2009) 1.53

Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1. Am J Physiol Renal Physiol (2007) 1.42

PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat (2004) 1.40

Differential diagnosis of fetal hyperechogenic cystic kidneys unrelated to renal tract anomalies: A multicenter study. Ultrasound Obstet Gynecol (2006) 1.37

Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. Clin J Am Soc Nephrol (2008) 1.33

Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors. Pediatr Nephrol (1997) 1.30

Nephronophthisis. Pediatr Nephrol (2010) 1.28

Autosomal recessive polycystic kidney disease. J Mol Med (Berl) (1998) 1.26

The place of liver transplantation in Caroli's disease and syndrome. Transpl Int (2006) 1.23

Mutation analysis in Bardet-Biedl syndrome by DNA pooling and massively parallel resequencing in 105 individuals. Hum Genet (2010) 1.19

Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1995) 1.17

Cyclic AMP, at the hub of the cystic cycle. Kidney Int (2004) 1.16

Autosomal recessive polycystic kidney disease in adulthood. Nephrol Dial Transplant (2001) 1.11

Hepatic cysts in autosomal dominant polycystic kidney disease. Mayo Clin Proc (1990) 1.10

Autosomal dominant polycystic kidney disease in the neonatal period: association with a cerebral arteriovenous malformation. Pediatrics (1982) 1.06

Polycystic kidney disease in the first year of life. J Pediatr (1987) 1.04

Heritable disorders of the bile ducts. Gastroenterol Clin North Am (2003) 1.02

Renal asymmetry in children with autosomal dominant polycystic kidney disease. Am J Kidney Dis (1999) 1.01

The spectrum of autosomal dominant polycystic kidney disease in children. J Am Soc Nephrol (1994) 0.99

Cystic diseases of the kidney: ciliary dysfunction and cystogenic mechanisms. Pediatr Nephrol (2010) 0.98

Practical genetics for autosomal dominant polycystic kidney disease. Nephron Clin Pract (2010) 0.98

Pathogenesis of hypertension in autosomal dominant polycystic kidney disease. Semin Nephrol (1991) 0.97

Renal cystic diseases: diverse phenotypes converge on the cilium/centrosome complex. Pediatr Nephrol (2006) 0.97

Morbidity from congenital hepatic fibrosis after renal transplantation for autosomal recessive polycystic kidney disease. Am J Transplant (2002) 0.95

Phenotypic heterogeneity in pediatric autosomal dominant polycystic kidney disease at first presentation: a single-center, 20-year review. Am J Kidney Dis (2004) 0.94

The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease. Pediatr Nephrol (2010) 0.94

Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease. Kidney Int (1991) 0.92

Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis (1998) 0.91

Gross genomic rearrangement involving the TSC2-PKD1 contiguous deletion syndrome: characterization of the deletion event by quantitative polymerase chain reaction deletion assay. Am J Kidney Dis (2007) 0.89

Aggressive surgical and medical management of autosomal recessive polycystic kidney disease. Urology (1993) 0.88

Chronic renal failure and portal hypertension--is portosystemic shunt indicated? Pediatr Nephrol (2000) 0.86

Evaluation and management of pain in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis (2010) 0.86

Dominant and recessive polycystic kidney disease in children: evaluation of clinical features and laboratory data. Pediatr Nephrol (1988) 0.86

Recurrent bacteremia with enteric pathogens in recessive polycystic kidney disease. Pediatr Nephrol (1999) 0.84

Autosomal dominant polycystic kidney disease with liver and pancreatic involvement in early childhood. Am J Kidney Dis (1989) 0.84

Congenital hepatic fibrosis in autosomal-dominant polycystic kidney disease. Kidney Int (1990) 0.84

Aggressive respiratory support and unilateral nephrectomy for infants with severe perinatal autosomal recessive polycystic kidney disease. J Pediatr (1995) 0.82

Diffuse renal cystic disease in children: morphologic and genetic correlations. Pediatr Nephrol (1998) 0.81

Introduction: new insights, treatments, and management strategies for ADPKD. Clin J Am Soc Nephrol (2008) 0.76